332.36
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LRCX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$337.01
Offen:
$332.36
24-Stunden-Volumen:
7.41M
Relative Volume:
0.66
Marktkapitalisierung:
$415.89B
Einnahmen:
$21.68B
Nettoeinkommen (Verlust:
$6.71B
KGV:
62.73
EPS:
5.298
Netto-Cashflow:
$6.00B
1W Leistung:
+6.75%
1M Leistung:
-3.97%
6M Leistung:
+41.11%
1J Leistung:
+209.52%
Lam Research Corp Stock (LRCX) Company Profile
Firmenname
Lam Research Corp
Sektor
Telefon
(510) 659-0200
Adresse
4650 CUSHING BLVD, FREMONT, CA
Compare LRCX vs ASML, AMAT, KLAC, TER
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
LRCX
Lam Research Corp
|
332.36 | 408.07B | 21.68B | 6.71B | 6.00B | 5.298 |
|
ASML
Asml Holding Nv
|
1,844.08 | 695.25B | 41.20B | 12.41B | 11.15B | 32.12 |
|
AMAT
Applied Materials Inc
|
507.18 | 435.21B | 29.02B | 8.51B | 5.34B | 10.64 |
|
KLAC
Kla Corp
|
203.72 | 272.09B | 13.09B | 4.67B | 4.01B | 3.5373 |
|
TER
Teradyne Inc
|
418.79 | 62.96B | 3.79B | 854.06M | 553.18M | 5.4031 |
Lam Research Corp Stock (LRCX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-02 | Herabstufung | Erste Group | Buy → Hold |
| 2026-01-29 | Hochstufung | Summit Insights | Hold → Buy |
| 2026-01-29 | Bestätigt | TD Cowen | Buy |
| 2026-01-15 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-01-15 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-10-23 | Bestätigt | TD Cowen | Buy |
| 2025-09-30 | Eingeleitet | HSBC Securities | Hold |
| 2025-09-29 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2025-09-23 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-09-22 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2025-09-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-08-14 | Fortgesetzt | Erste Group | Buy |
| 2025-07-31 | Herabstufung | Summit Insights | Buy → Hold |
| 2025-07-31 | Bestätigt | TD Cowen | Buy |
| 2025-07-10 | Eingeleitet | Goldman | Buy |
| 2025-04-24 | Bestätigt | TD Cowen | Buy |
| 2025-03-20 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-02-20 | Hochstufung | Susquehanna | Neutral → Positive |
| 2025-01-30 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-01-30 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-17 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-01-15 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-12-17 | Eingeleitet | Cleveland Research | Neutral |
| 2024-08-01 | Bestätigt | TD Cowen | Buy |
| 2024-05-13 | Eingeleitet | Jefferies | Buy |
| 2024-04-25 | Bestätigt | TD Cowen | Buy |
| 2024-04-19 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2024-04-18 | Bestätigt | Needham | Buy |
| 2024-04-16 | Eingeleitet | Evercore ISI | Outperform |
| 2024-04-11 | Fortgesetzt | Deutsche Bank | Hold |
| 2024-01-25 | Bestätigt | TD Cowen | Outperform |
| 2024-01-23 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-12-12 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-12-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-22 | Eingeleitet | Redburn Atlantic | Buy |
| 2023-10-17 | Eingeleitet | Raymond James | Outperform |
| 2023-10-13 | Hochstufung | Needham | Hold → Buy |
| 2023-09-15 | Eingeleitet | Wolfe Research | Outperform |
| 2023-07-24 | Bestätigt | Mizuho | Buy |
| 2023-07-24 | Hochstufung | Stifel | Hold → Buy |
| 2023-04-20 | Bestätigt | Berenberg | Buy |
| 2023-04-20 | Bestätigt | Evercore ISI | Outperform |
| 2023-04-20 | Bestätigt | JP Morgan | Overweight |
| 2023-04-20 | Bestätigt | Jefferies | Buy |
| 2023-04-20 | Bestätigt | Mizuho | Buy |
| 2023-04-20 | Bestätigt | Stifel | Hold |
| 2023-04-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2023-03-13 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-01-18 | Fortgesetzt | Stifel | Hold |
| 2022-12-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-10-20 | Bestätigt | B. Riley Securities | Neutral |
| 2022-10-20 | Bestätigt | BofA Securities | Buy |
| 2022-10-20 | Bestätigt | DA Davidson | Neutral |
| 2022-10-20 | Bestätigt | Evercore ISI | Outperform |
| 2022-10-20 | Bestätigt | JP Morgan | Overweight |
| 2022-10-20 | Bestätigt | Jefferies | Buy |
| 2022-10-20 | Hochstufung | Summit Insights | Hold → Buy |
| 2022-10-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-07-25 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-06-15 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2022-01-27 | Bestätigt | Barclays | Overweight |
| 2022-01-27 | Bestätigt | Deutsche Bank | Hold |
| 2022-01-27 | Bestätigt | Evercore ISI | Outperform |
| 2022-01-27 | Bestätigt | Stifel | Buy |
| 2022-01-27 | Bestätigt | Susquehanna | Neutral |
| 2022-01-27 | Bestätigt | UBS | Buy |
| 2022-01-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-01-12 | Bestätigt | Barclays | Overweight |
| 2022-01-10 | Bestätigt | BofA Securities | Buy |
| 2022-01-05 | Fortgesetzt | Jefferies | Buy |
| 2021-12-15 | Bestätigt | Deutsche Bank | Hold |
| 2021-10-21 | Bestätigt | B. Riley Securities | Buy |
| 2021-10-21 | Herabstufung | Summit Insights | Buy → Hold |
| 2021-10-15 | Eingeleitet | Piper Sandler | Neutral |
| 2021-09-14 | Herabstufung | Susquehanna | Positive → Neutral |
| 2021-09-07 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2021-07-29 | Bestätigt | Mizuho | Buy |
| 2021-07-29 | Bestätigt | Stifel | Buy |
| 2021-07-29 | Bestätigt | UBS | Buy |
| 2021-07-29 | Bestätigt | Wells Fargo | Equal Weight |
| 2021-03-31 | Eingeleitet | Bernstein | Outperform |
| 2021-01-28 | Bestätigt | Cowen | Outperform |
| 2021-01-08 | Herabstufung | Needham | Buy → Hold |
| 2020-12-17 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2020-10-22 | Bestätigt | Goldman | Buy |
| 2020-10-22 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-10-22 | Bestätigt | Mizuho | Buy |
| 2020-10-22 | Bestätigt | Morgan Stanley | Overweight |
| 2020-10-22 | Bestätigt | RBC Capital Mkts | Outperform |
| 2020-10-22 | Bestätigt | Stifel | Buy |
| 2020-10-22 | Bestätigt | UBS | Buy |
| 2020-09-21 | Hochstufung | Stifel | Hold → Buy |
| 2020-07-30 | Bestätigt | Cowen | Outperform |
| 2020-07-21 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2020-06-22 | Herabstufung | Stifel | Buy → Hold |
| 2020-06-16 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-26 | Eingeleitet | Barclays | Overweight |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-04-08 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2020-04-03 | Hochstufung | Nomura | Neutral → Buy |
| 2020-04-02 | Herabstufung | DA Davidson | Buy → Neutral |
| 2020-03-27 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-03-27 | Hochstufung | UBS | Sell → Buy |
Alle ansehen
Lam Research Corp Aktie (LRCX) Neueste Nachrichten
Westwind Capital Purchases Shares of 5,637 Lam Research Corporation $LRCX - MarketBeat
Prospera Financial Services Inc Has $31.15 Million Stock Position in Lam Research Corporation $LRCX - MarketBeat
Independent Financial Group LLC Raises Holdings in Lam Research Corporation $LRCX - MarketBeat
Shaker Investments LLC OH Has $4.92 Million Stock Position in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Stock Holdings Lowered by Range Financial Group LLC - MarketBeat
Canada Post Corp Registered Pension Plan Has $44.83 Million Stock Position in Lam Research Corporation $LRCX - MarketBeat
Brookstone Capital Management Grows Position in Lam Research Corporation $LRCX - MarketBeat
Bar Harbor Wealth Management Has $15.07 Million Position in Lam Research Corporation $LRCX - MarketBeat
Chipmaking equipment supplier Lam Research to spend $3B+ on new labs - siliconangle.com
Lam Research (NASDAQ:LRCX) Shares Down 1.4%Here's Why - MarketBeat
KG Capital Management's Lam Research Corp(LRCX) Holding History - GuruFocus
Lam Research to Boost R&D Capacity 50% as Stock Consolidates Near Key Technical Levels - finance.biggo.com
Lam Research (NASDAQ: LRCX): AI Growth Meets Cycle Risks - Kalkine Media
Why Lam Research (LRCX) Became This Portfolio’s Top Performer - finance.yahoo.com
Lam Research Corporation $LRCX Shares Sold by YHB Investment Advisors Inc. - MarketBeat
What's Going On With Lam Research Stock Friday? - Benzinga
Lam Research Commits $3 Billion to Expand AI Chip R&DLam Research (NASDAQ:LRCX) - Benzinga
QRG Capital Management Inc. Grows Position in Lam Research Corporation $LRCX - MarketBeat
Wealthcare Advisory Partners LLC Sells 38,231 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Shares Bought by Cache Advisors LLC - MarketBeat
Burney Co. Sells 30,723 Shares of Lam Research Corporation $LRCX - MarketBeat
Fisher Funds Management LTD Has $13.57 Million Stake in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation (NASDAQ:LRCX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Lam Research stock jumps after $3 billion R&D plan and strong year-to-date rally - AD HOC NEWS
Lam Research Plans $3B R&D Expansion to Increase Experiment Capacity By 50% -- Company Talk - moomoo.com
Lam Research (NASDAQ:LRCX) Trading 3.3% HigherHere's What Happened - MarketBeat
Lam Research plans $3B R&D expansion over five years - Investing.com
Is Lam Research Corp (LRCX) Overvalued After 3.3% Rally? GF Valu - GuruFocus
Lam Research Announces Plans to Invest More than $3B to Expand Global Lab Network - techpowerup.com
Lam Research plans $3B R&D expansion over five years By Investing.com - Investing.com Nigeria
Lam Research Corp. stock outperforms competitors on strong trading day - MarketWatch
Lam Research Announces Plans to Invest More than $3B to Expand Global Lab Network, Increase Innovation Velocity in the AI Era - The Missoulian
SanDisk, Lam Research among market cap stock movers on Thursday - Investing.com
SanDisk, Lam Research among market cap stock movers on Thursday By Investing.com - Investing.com India
Lam Research Corp Stock (LRCX) Moved Up by 3.22% on Aug 13: Drivers Behind the Movement - TradingKey
What's Going On With Lam Research Stock Thursday? - TradingView
Y Intercept Hong Kong Ltd Has $13.60 Million Holdings in Lam Research Corporation $LRCX - MarketBeat
Gradient Capital Advisors LLC Sells 4,983 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Shares Sold by Patton Fund Management Inc. - MarketBeat
Ardsley Advisory Partners LP Invests $4.33 Million in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corp (LRCX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Credit Capital Investments LLC's Lam Research Corp(LRCX) Holding History - GuruFocus
Lam Research to Add 200 Singapore Roles as Advanced Chipmaking Demand Grows - EE Times Asia
LRCX|Lam Research Corp|Price:325.170|Chg%:-0.940 - TradingKey
LUTS & GREENLEIGH GROUP, INC.'s Lam Research Corp(LRCX) Holding History - GuruFocus
Is Lam Research Corp (LRCX) Overvalued After 4.7% Rally? GF Valu - GuruFocus
Lam Research (NASDAQ:LRCX) Stock Price Up 4.7%Here's What Happened - MarketBeat
Lam Research, NY Creates Collaborate on Semiconductor Training for Students - Moomoo
Lam Research Gains as Strong Earnings Momentum and Chip-Spending Optimism Lift Shares - Moomoo
Lam Research Corp Stock (LRCX) Opened Up by 4.92% on Aug 12: What Investors Need To Know - TradingKey
July CPI Cools To 3.4%: Why Bloom Energy, SanDisk Stocks RalliedKeyCorp (NYSE:KEY), Lam Research (NASD - Benzinga
Finanzdaten der Lam Research Corp-Aktie (LRCX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Lam Research Corp-Aktie (LRCX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| ARCHER TIMOTHY | President and CEO |
Aug 06 '26 |
Sale |
300.00 |
30,000 |
9,000,000 |
1,075,966 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):